EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS155-08926 
Organism
Homo sapiens 
Tissue/cell
Ovary 
Coordinate
chr20:43229350-43231030 
TF binding sites/motifs
Number: 5             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ESRRBMA0141.3chr20:43230720-43230731TCAAGGTCAAT+6.02
EsrraMA0592.2chr20:43230719-43230730TTCAAGGTCAA+6.14
NR2C2MA0504.1chr20:43230649-43230664TAACCTCTGACCCCA-6.37
RxraMA0512.2chr20:43230649-43230663TAACCTCTGACCCC-6
ZNF263MA0528.1chr20:43230777-43230798TGAGGATGAGGAAAAGAAAGA+6.31
Number of super-enhancer constituents: 30             
IDCoordinateTissue/cell
SE_00279chr20:43224263-43232491Adipose_Nuclei
SE_01271chr20:43228234-43231189Adrenal_Gland
SE_01849chr20:43224747-43231317Aorta
SE_03744chr20:43229748-43230493Brain_Angular_Gyrus
SE_03744chr20:43230637-43231230Brain_Angular_Gyrus
SE_04325chr20:43228328-43231366Brain_Anterior_Caudate
SE_05260chr20:43229259-43231417Brain_Cingulate_Gyrus
SE_05994chr20:43225116-43231394Brain_Hippocampus_Middle
SE_07387chr20:43229008-43231429Brain_Hippocampus_Middle_150
SE_08237chr20:43228359-43231409Brain_Inferior_Temporal_Lobe
SE_10419chr20:43228321-43231318CD19_Primary
SE_10988chr20:43207149-43236350CD20
SE_25405chr20:43230281-43231193DND41
SE_26047chr20:43225817-43231582Duodenum_Smooth_Muscle
SE_38551chr20:43225581-43231426HUVEC
SE_40873chr20:43224620-43233599Left_Ventricle
SE_42448chr20:43224637-43231354Lung
SE_44474chr20:43228464-43231228NHDF-Ad
SE_48409chr20:43228253-43231170Psoas_Muscle
SE_48778chr20:43227693-43231314Right_Atrium
SE_51576chr20:43224647-43231541Skeletal_Muscle
SE_54142chr20:43225188-43231311Spleen
SE_54929chr20:43225685-43231607Stomach_Smooth_Muscle
SE_58424chr20:43199983-43247676Ly1
SE_58843chr20:43204266-43231338Ly3
SE_59727chr20:43187804-43239602Ly4
SE_60908chr20:43204757-43248014DHL6
SE_61085chr20:43204394-43239507HBL1
SE_61654chr20:43199842-43247312Toledo
SE_62478chr20:43204535-43247707Tonsil
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr204322960043231000
Enhancer Sequence
AAATGACAGG ACTGGGTAAA GAATTGTCCA TGGGTGGTGA AGAAGAAGCG AGGTCAGGGA 60
TGGTCCTGGG TTTCCAGCTG GGCAGATGGT GGTGCCCTTG CTCAGTTGGG AAGGCCGTGG 120
CGAGCAGGCT GGTGACTTGA CGTCTGAAGC TTGCAGTGCT GTGGGATAGC CAAATGACAC 180
GCTCAATAGG CTGAGTCAGA AATCTAGAAC TCTTAAGAGA GGGTTGCAGC TCTTTGAAGG 240
TCACCAACAT AGATTATTTC GGGAAAGGAT AAGAGCCCCT CGGGAGCAAA CAGAAGAGAC 300
TGGCGTCCTA ACACAAAGGT CCCGGCAGTA GCAGGTGCCT GTGCAGACTG GTTGGAGGGA 360
GGCCCAAAGG GTGTGGTGTC TGGAAGTCCC ATGAAGAGAA TGGTCCGGGA AGAAATGAGT 420
TGGAAGAGGA GGACAGAAAG GTGTCCCTGG GGATAGGCAC CGTAGAAGTC ACTCAGGACC 480
TTGTCTGACT TGAGCACCCT GACCTTCCCT TCCTATCACT GCCTGCATCC AGGCCTGCTT 540
GGGTCTAGGC CTGGCAGGTG CAGAGGCCAA GGCCCGGCCT CTCTGCCTCC AAACAAAGCC 600
TCACCCAGGG CCACTCTTTG AATGGCAACA GGCACTGCCC AGGCAGGCGA CAGGCTCCTC 660
TCTGGTGACC TTGTGCTGGA TGTGCCCCAA GGCGCTGGGT AGGGCTTTGC AGCCAGCCCC 720
AGGCAGGCCA CACATGGATA GAACCGGCAG CCCTCCCTTT TCCCAGGTTC TTGGAATATT 780
CTCATTTTGG GGCTCTGAGT TTTCTGTTGG CCTCAGTGCC TCTCTTTTCT GGCTTTCTAT 840
CACAGAGAGA AGCCGCTACC CTTGAAATTT GATGAATGCC TGTTCAGTAG GCCCTGGCAT 900
TTCTGTTTCC ACGGCCCTTT CGTCCCTCAG AGAAGCCTTA GAGAGCATTT TGCCCACCCC 960
TGATAAAACT TCTCCCATAA GACCAGGTCC CACTTCTGTG CTTCATGTCT TCTGCAAAAG 1020
TCTGTTTGCT TTTTGTATGG TTTCTGCAAA TACTGAATTT TTGAAAAAGA AAAAAAAACA 1080
GGAAATGACC TTTCTAGTAT ATTTGGAAAA CAATTTGGAG CTTGTAATGG AATCTGCCTG 1140
AGCAATGAGG ACTAATAGCT GCAGACTTGG AACAGACCAT GTAGCTCTTG GCAGAGCCTG 1200
GGGCCTCTTC AGTTTACAAA GCTGGGGGGA GTATTAGAAA CCCACGGGAG AAGTGGCTTC 1260
CTGTGGGGAA ATGCCCAGAG CAGGCACCTG CAGGCACTGT AACCTCTGAC CCCAGGGCCC 1320
CAAAAGGCCT GGGGACAGAG TATAAGGGCT TCACCCTTTG TCCTGGGCAT TCAAGGTCAA 1380
TCACATGTCT GGCAATCATC CAGATCCCAC AAGATACCAA AACCTCCTGA GGATGAGGAA 1440
AAGAAAGAGC TTCATTCTTT AGCACCCTGT AGGGCTCAGG CTGAGCTAGA AGATTCTAGA 1500
TTGTTTTTAG ACTCAAATTG CCTGTTGGCT CTCTGGGTCC CTCTCTATCC AACTTTTCTG 1560
TAGATTTCAG CAAAAACCAC CTCCTCAGAG AGGCCTTTCC TGATCATACA GCCATTAACT 1620
GCATGATCCA CATGCAGAGA ACCCTCTCCT CTTCTCCCAT AGCACATACC ATAATCTGTG 1680